Silke Frenz

678 citations
6 papers · 531 indexed · 1 hit paper · h-index 4
Topics
CAR-T cell therapy research (6 papers)Virus-based gene therapy research (2 papers)Biosimilars and Bioanalytical Methods (2 papers)

In The Last Decade

Silke Frenz

6 papers receiving 528 citations

Hit Papers

The tyrosine kinase inhibitor dasatinib acts as a pharmac...20192026202120232019100200300

Peers

Silke Frenz
Comparison fields: 5 of 40
  • Oncology 459
  • Biomedical Engineering 187
  • Molecular Biology 180
  • Immunology 163
  • Genetics 147
Replace Andreas Mades with:
Andreas Mades Germany
Katrin Mestermann Germany
Aaron Zhang United States
Irene Michalk Germany
Benjamin Draper United Kingdom
Andrea V. Lopez United States
Simon Loff Germany
Ian R. Hardy United States
Stefanie Lesch Germany
Claudia Geldres United States
Silke Frenz relative to Andreas Mades Germany Andreas Mades's profile →
Citations per field
00.5×1.7×
Andreas Mades · 1×
Citations per year

Countries citing papers authored by Silke Frenz

Since Specialization
Citations

This map shows the geographic impact of Silke Frenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Frenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Frenz more than expected).

Fields of papers citing papers by Silke Frenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Frenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Frenz. The network helps show where Silke Frenz may publish in the future.

Co-authorship network of co-authors of Silke Frenz

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Frenz. A scholar is included among the top collaborators of Silke Frenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Frenz. Silke Frenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 24
2 74
3
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cellsbreakdown →
379
4 1
5 52
6 1

About Silke Frenz

Silke Frenz is a scholar working on Oncology, Immunology and Immunology and Allergy, having authored 6 papers that have together received 531 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Virus-based gene therapy research (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). The work is most often cited by research in Oncology (459 citations), Immunology (163 citations) and Genetics (147 citations). Silke Frenz has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Hermann Einsele, Michael Hudecek, Andreas Mades, Katrin Mestermann, Justus Weber, Theodoros Giavridis, Julian Rydzek, Thomas Nerreter, Michel Sadelain and Christoph Rader. Their work appears in journals such as Blood, Science Translational Medicine and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026